Serum OX40 ligand levels in asthmatic children: A potential biomarker of severity and persistence

Allergy and Asthma Proceedings

Volumn 32, Issue 4, 2011, Pages 313-318

  Ezzat, Mohamed Hesham Mohamed ^a   Imam, Safaa Shafik ^a   Shaheen, Kareem Yehia Ali ^a   Elbrhami, Emhemed Mossbah ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b UNIVERSITY OF ZAWIA   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; OX40 LIGAND;

ALLERGIC ASTHMA; ARTICLE; ASTHMA; CHILDHOOD DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PROTEIN BLOOD LEVEL; REMISSION; UPREGULATION;

ADOLESCENT; ASTHMA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EOSINOPHILS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LEUKOCYTE COUNT; MALE; OX40 LIGAND; PEAK EXPIRATORY FLOW RATE; SEVERITY OF ILLNESS INDEX; TH2 CELLS; UP-REGULATION;

EID: 79960715523     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3447     Document Type: Article

References (31)

1. Ruby CE, Yates MA, Hirschhorn-Cymerman D, et al. Cutting edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right. J Immunol 183:4853- 4857, 2009.
2. Mousavi SF, Soroosh P, Takahashi T, et al. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J Immunol 181:5990-6001, 2008.
3. Soroosh P, Ine S, Sugamura K, and Ishii N. Differential requirements for OX40 signals on generation of effector and central memory CD4+ T cells. J Immunol 179:5014 -5023, 2007.
4. Soroosh P, Ine S, Sugamura K, and Ishii N. OX40-OX40 Ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity. J Immunol 176:5975-5987, 2006.
5. Hoshino A, Tanaka Y, Akiba H, et al. Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma. Eur J Immunol 33:861- 869, 2003.
6. Liu AH, Spahn JD, and Leung DY. Childhood asthma. In Nelson Textbook of Pediatrics, 17th ed. Behrman RE, Kleigman RM, and Jenson HB (Eds). Philadelphia, PA: WB Saunders, 760-773, 2004.
7. Global Initiative for Asthma Guidelines (GINA). Global strategy for asthma management and prevention. Workshop Report, updated April 2002, Scientific information and recommendations for asthma programs, National Institutes of Health (NIH) Publication No. 02-3659.
8. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention program. J Allergy Clin Immunol 110: S141, 2002.
9. National Heart, Lung, and Blood Institute (NHLBI). Global Initiative for Asthma program: Pocket guide for asthma management and prevention in children (updated from the NHLBI/WHO workshop Report: Global Strategy for Asthma Management and Prevention issued January 1995, and revised 2002). National Institutes of Health (NIH) Publication No. 02-3659, U.S. Department of Health and Human Services, NIH, Bethesda, MD, 2003.
10. Geaghan SM. Normal blood values: Selected reference values for neonatal, pediatric and adult populations. In Hematology Basic Principles and Practice, 3rd ed. Hoffman R, Benz EJ, Shattil SJ, et al. (Eds). New York: Churchill Livingston, 2520-2528, 2000.
11. Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol 120:238 -244, 2007.
12. Arestides RS, He H, Westlake RM, et al. Costimulatory molecule OX40L is critical for both Thl and Th2 responses in allergic inflammation. Eur J Immunol 32:2874 -2880, 2002.
13. Salek-Ardakani S, Song J, Halteman BS, et al. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 198:315-324, 2003. (Pubitemid 36987856)
14. Seshasayee D, Lee WP, Zhou M, et al. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest 117:3868 -3878, 2007.
15. Wang YH, and Liu YJ. OX40-OX40L interactions: A promising therapeutic target for allergic diseases? J Clin Invest 117:3655-3657, 2007.
16. Burgess JK, Blake AE, Boustany S, et al. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol 115:302-308, 2005. (Pubitemid 40215093)
17. Burgess JK, Carlin S, Pack RA, et al. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: A possible role in asthma? J Allergy Clin Immunol 113:683- 689, 2004.
18. Krimmer DI, Loseli M, Hughes JM, et al. CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle. Allergy 64:1074 -1082, 2009.
19. Siddiqui S, Mistry V, Doe C, et al. Airway wall expression of OX40/OX40L and interleukin-4 in asthma. Chest 137:797-804, 2010.
20. Wang YH, and Liu YJ. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clin Exp Allergy 39:798-806, 2009.
21. Croft M, So T, Duan W, and Soroosh P. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 229:173-191, 2009.
22. Takeda I, Ine S, Killeen N, et al. Distinct roles for the OX40-OX40 ligand interaction in regulatory and non-regulatory T cells. J Immunol 172:3580 -3589, 2004.
23. Ukyo N, Hori T, Yanagita S, et al. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response. Immunology 109:226 -231, 2003.
24. Ishii N, Ndhlovu LC, Murata K, et al. OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses. Eur J Immunol 33:2372-2381, 2003. (Pubitemid 37138969)
25. Kondo K, Okuma K, Tanaka R, et al. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells. Hum Immunol 68:563-571, 2007. (Pubitemid 46920559)
26. Hori T. Roles of OX40 in the pathogenesis and the control of diseases. Int J Hematol 83:17-22, 2006. (Pubitemid 43172737)
27. Jenkins SJ, Perona-Wright G, Worsley AGF, et al. Dendritic cell expression of OX40 Ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo. J Immunol 179:3515-3523, 2007.
28. Linton PJ, Bautista B, Biederman E, et al. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med 197:875- 883, 2003.
29. Lane P. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J Exp Med 191:201-206, 2000.
30. De Smedt T, Smith J, Baum P, et al. OX40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J Immunol 168:661- 670, 2002.
31. Kim MY, Bekiaris V, McConnell FM, et al. OX40 signals during priming on dendritic cells inhibit CD4 7 cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors. J Immunol 174:1433-1437, 2005.